Search results
...Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute ...
Morningstar· 23 hours ago“We are delighted to safely progress through the second, higher dose cohort to reach an important study milestone for the United States Food and Drug Administration...
Potential new treatment strategy for aggressive leukemia
Medical Xpress· 20 hours agoIn findings published in Nature Cancer, researchers reveal that blocking these oxygen-sensing enzymes can significantly halt acute myeloid leukemia ...
European Medicines Agency (EMA) Grants Orphan Drug Designation for Moleculin's Treatment of Acute ...
NBC 17 Raleigh· 22 hours ago– Next-generation non-cardiotoxic anthracycline Annamycin with notable signs of clinical efficacy in AML in combination with Cytarabine achieves preliminary CRc rate of 60% in 2nd line AML subjects ...
Why Is Bio-Path (BPTH) Stock Up 89% Today?
InvestorPlace· 20 hours agoBio-Path (NASDAQ:BPTH) stock is rising higher on Thursday after the oncology company announced an update on its Phase 1/1b clinical trial of BP1002. This...
Report: Europe leads in number of clinical trials for cystic fibrosis, North America for AML
FierceBiotech· 3 days agoEurope has launched the most clinical trials for cystic fibrosis (CF) treatments, while North...
New way found to treat early relapse in leukemia
Medical Xpress· 4 days agoDespite the best treatment, many patients with AML have recurrent disease within the first two years. This MRD test provides advanced warning that the...
BiVictriX Therapeutics AML treatment granted orphan drug status by FDA
Proactive Investors· 2 days agoThe designation recognises BVX001’s potential to address a significant unmet medical need, the...
The Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and...
Zacks via Yahoo Finance· 7 days agoRegulatory Update from Syros: Syros Pharmaceuticals announced that the FDA has granted Fast Track...
Newswise Expert | Namrata Chandhok, University of Miami Health System, Miller School of Medicine
Newswise· 4 days agoNamrata Chandhok, M.D. is an Assistant Professor of Clinical Medicine (Hematology) at the University of Miami Miller School of Medicine/ Sylvester Comprehensive Cancer Center. Dr. Chandhok specializes ...
AACR: Biotechs emerge frostbitten from 'nuclear winter,' ready to show why they fought for survival
FierceBiotech· 20 hours agoA thinner, leaner biotech forest arrived at the American Association for Cancer Research (AACR)...